Yalcin-Ülker, G.M.; Günbatan, M.; Duygu, G.; Soluk-Tekkesin, M.; Özcakir-Tomruk, C.
Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw? Biomedicines 2023, 11, 758.
https://doi.org/10.3390/biomedicines11030758
AMA Style
Yalcin-Ülker GM, Günbatan M, Duygu G, Soluk-Tekkesin M, Özcakir-Tomruk C.
Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw? Biomedicines. 2023; 11(3):758.
https://doi.org/10.3390/biomedicines11030758
Chicago/Turabian Style
Yalcin-Ülker, Gül Merve, Murat Günbatan, Gonca Duygu, Merva Soluk-Tekkesin, and Ceyda Özcakir-Tomruk.
2023. "Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?" Biomedicines 11, no. 3: 758.
https://doi.org/10.3390/biomedicines11030758
APA Style
Yalcin-Ülker, G. M., Günbatan, M., Duygu, G., Soluk-Tekkesin, M., & Özcakir-Tomruk, C.
(2023). Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw? Biomedicines, 11(3), 758.
https://doi.org/10.3390/biomedicines11030758
